ArticleBreast (Edinburgh, Scotland)2020
The ethical, legal and social implications of using artificial intelligence systems in breast cancer care.
Article in Breast (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
105 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- Ethical implications of the use of AI-based technologies for medical image classification systems in screening: a qualitative systematic review.Health technology assessment (Winchester, England) · 2026Pooled it
- Challenges in Implementing Artificial Intelligence in Breast Cancer Screening Programs: Systematic Review and Framework for Safe Adoption.Journal of medical Internet research · 2025Pooled it
- Physicians' required competencies in AI-assisted clinical settings: a systematic review.British medical bulletin · 2025Pooled it
- Precision cancer medicine and the doctor-patient relationship: a systematic review and narrative synthesis.BMC medical informatics and decision making · 2023Pooled it
- Mammography diagnosis of breast cancer screening through machine learning: a systematic review and meta-analysis.Clinical and experimental medicine · 2023Pooled it
- Use of artificial intelligence for image analysis in breast cancer screening programmes: systematic review of test accuracy.BMJ (Clinical research ed.) · 2021Pooled it
- Should AI results be disclosed in mammography reports? A randomised survey study of patient responses to concordant and discordant interpretations.European radiology · 2026Trial
- Artificial intelligence in cancer diagnosis and therapy using sex and gender as precision biomarkers.Discover oncology · 2026Review
- Machine learning enhanced optical spectroscopy for breast cancer diagnosis: A review.Lasers in medical science · 2026Review
- The Role of Explanations in AI-Generated Alerts: Qualitative Study of Clinical Views on Explainable AI in Predictive Tools.JMIR human factors · 2026Article
- A distributed fusion framework for breast cancer recurrence prediction using MapReduce.Scientific reports · 2026Article
- Patient Perceptions of Artificial Intelligence in Diabetes Self-Management: Cross-Sectional Survey Study.JMIR formative research · 2026Article
- Bridging Pixels and Practice: AI-Assisted Mammography as a Next-Generation Diagnostic Strategy for Breast Cancer Screening.Diagnostics (Basel, Switzerland) · 2026Review
- Patient Perceptions of Artificial Intelligence in Orthopaedic Surgery: Identifying Potential Barriers to Acceptance and Disparities With Implementation.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026Article
- Transforming Gastric Biopsy Diagnostics: Integrating Omics Technologies and Artificial Intelligence.Biomedicines · 2026Article
- Legal and ethical reflections on the use of artificial intelligence in the diagnosis and treatment of cancer: who assumes responsibility?Frontiers in artificial intelligence · 2026Article
- AI-enabled multi-omics integration in colorectal cancer: from molecular stratification to clinical translation.Frontiers in cell and developmental biology · 2026Review
- Implementation of AI in oncology: a systematic review of educational and clinical integration in global contexts.Frontiers in digital health · 2026Review
- A quantitative study of pathologists' perceptions towards artificial intelligence-assisted diagnostic system.PLOS digital health · 2025Article
- Artificial intelligence in the diagnosis and management of gynecologic cancer.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Review
45 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer care is a leading area for development of artificial intelligence (AI), with applications including screening and diagnosis, risk calculation, prognostication and clinical decision-support, management planning, and precision medicine. We review the ethical, legal and social implications of these developments. We consider the values encoded in algorithms, the need to evaluate outcomes, and issues of bias and transferability, data ownership, confidentiality and consent, and legal, moral and professional responsibility. We consider potential effects for patients, including on trust in healthcare, and provide some social science explanations for the apparent rush to implement AI solutions. We conclude by anticipating future directions for AI in breast cancer care. Stakeholders in healthcare AI should acknowledge that their enterprise is an ethical, legal and social challenge, not just a technical challenge. Taking these challenges seriously will require broad engagement, imposition of conditions on implementation, and pre-emptive systems of oversight to ensure that development does not run ahead of evaluation and deliberation. Once artificial intelligence becomes institutionalised, it may be difficult to reverse: a proactive role for government, regulators and professional groups will help ensure introduction in robust research contexts, and the development of a sound evidence base regarding real-world effectiveness. Detailed public discussion is required to consider what kind of AI is acceptable rather than simply accepting what is offered, thus optimising outcomes for health systems, professionals, society and those receiving care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.